biotech investing Standard BioTools Announces Sale of Mass Cytometry Business and Illumina's Buyout of Contingent Payments to Advance Merger with Treeline Biosciences
biotech investing Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026
biotech investing Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction
biotech investing Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
biotech investing Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Angkor Resources Presents Its Proposed 2027 Work Program For Block Viii To The Cambodian Government At The Joint Review Committee
Blue Jay Gold Announces Materials Purchase Agreement With Ocean Partners for Remediation Material at Steller
SAGA Metals Completes Diamond Drill Program at the Wolverine Rare Earth Project - All 22 Holes Totalling 3,241 Metres Intersect Prospective REE-Bearing Alteration
